Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Mar;65(3):1273-85.
doi: 10.1128/JVI.65.3.1273-1285.1991.

Virological events leading to spontaneous AKR thymomas

Affiliations

Virological events leading to spontaneous AKR thymomas

J P Stoye et al. J Virol. 1991 Mar.

Abstract

The spontaneous leukemias of AKR mice are caused by mink cell focus-forming (MCF) viruses. These viruses are generated by recombination between several endogenous murine retroviruses. The virological events leading to the generation of the leukemogenic agent were investigated by using an oligonucleotide specific for the U3 region of the leukemogenic virus and env-reactive oligonucleotide probes specific for the different classes of endogenous murine leukemia virus. It was shown that (i) the leukemogenic MCF virus is formed by recombination between at least three different endogenous sequences; (ii) the U3 donor for the leukemogenic virus is the inducible xenotropic virus Bxv-1; (iii) all spontaneous tumors contain viruses with duplicated enhancer regions in their long terminal repeats; (iv) enhancer duplication is a somatic event, since Bxv-1 contains only one copy; (v) the first recombinant virus detectable in mass populations of thymocytes by Southern hybridization analysis contains all structural features of the ultimate leukemogenic virus; and (vi) the multiple novel viruses in a given tumor represent progeny of the same unique recombination events. On the basis of these results, an analysis of the virological events leading to AKR thymomas is presented.

PubMed Disclaimer

References

    1. J Exp Med. 1972 Nov 1;136(5):1272-85 - PubMed
    1. J Virol. 1983 Jan;45(1):291-8 - PubMed
    1. J Virol. 1983 Jan;45(1):275-90 - PubMed
    1. J Virol. 1982 Nov;44(2):625-36 - PubMed
    1. J Virol. 1980 Jan;33(1):238-49 - PubMed

Publication types

MeSH terms